Simvastatin

CAS 79902-63-9 16 current records 14 historicalSmall Molecule

Who holds supplier records for Simvastatin? 16 organisations hold a current record for Simvastatin: an active US FDA Type II Drug Master File or a CEP. A further 14 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), China (5), Israel (1) and Netherlands (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Simvastatin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/simvastatin

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Simvastatin expires 23 Feb 2030. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Simvastatin. Country is the organisation's recorded country, not necessarily the manufacturing site.

India6China5Israel1Netherlands1Country not recorded for 3
  • Teva Pharmaceutical Industries Ltd.
    Active DMF 14599, 25024 · latest filing Jun 2011
    IsraelCEP Company GMP cert on record
  • Zhejiang Jiangbei Pharmaceutical Co., Ltd.
    Active DMF 26971, 28583 · latest filing Aug 2014
    ChinaCEP
  • Biocon Limited
    Active DMF 18449, 16094 · latest filing Jun 2005
    IndiaCEP
  • HENAN TOPFOND SCI-TECH CO LTD
    Active DMF 34089 · latest filing Aug 2019
    ChinaCEP
  • Hetero Labs Limited
    Active DMF 23012, 27231 · latest filing Jun 2013
    IndiaCEP Company GMP cert on record
  • Lupin Limited
    Active DMF 17934 · latest filing Dec 2004
    IndiaCEP Company GMP cert on record
  • ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTD
    Active DMF 40384 · latest filing Sept 2024
    CEP Company GMP cert on record
  • JUBILANT BIOSYS LTD
    Active DMF 18755 · latest filing Sept 2005
    India
  • SOUTHWEST SYNTHETIC PHARMACEUTICAL CORP LTD
    Active DMF 23425 · latest filing Dec 2009
    China
  • ARTEMIS BIOTECH
    Inactive DMF 18522 · latest filing Jul 2005
    CEP
  • KREBS BIOCHEMICALS AND INDUSTRIES LTD
    CEP Company GMP cert on record
  • Shaoxing Jingxin Pharmaceutical Co., Ltd.
    ChinaCEP
  • Sun Pharmaceutical Industries Limited
    Inactive DMF 15722 · latest filing Nov 2001
    IndiaCEP Company GMP cert on record
  • NetherlandsCEP
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inactive DMF 26048, 16305 · latest filing May 2012
    ChinaCEP Company GMP cert on record
  • Artemis Biotech (A Division of Themis Medicare Limited)
    Valid CEP holder (EDQM); not necessarily the manufacturer
    IndiaCEP
Need Simvastatin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Simvastatin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 46 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
BIOCON LIMITED BengaluruIN
CEP 2012-337 - Rev 04
Simvastatin
Nov 2026—
TAPI NL B.V. AmsterdamNL
CEP 2013-216 - Rev 04
Simvastatin, Ethanol/acetonitrile process
Jun 2026—
SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. ShangyuCN
CEP 2017-184 - Rev 04
Simvastatin, BHA process
Aug 2025—
ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai CityCN
CEP 2022-245 - Rev 02
Simvastatin
Mar 2025Inspected Oct 2025
France
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2001-384 - Rev 09
Simvastatin
Feb 2025—
ARTEMIS BIOTECH LIMITED HyderabadIN
CEP 2023-416 - Rev 00
Simvastatin, Process II, Antioxidant Butylated Hydroxy Toluene 0.01%
Apr 2024—
KREBS BIOCHEMICALS & INDUSTRIES LIMITED KothapalliIN
R1-CEP 2007-210 - Rev 02
Simvastatin, with 0.2% butylated hydroxy anisole
Aug 2023—
HENAN TOPFOND SCI-TECH CO., LTD. ZhumadianCN
R1-CEP 2006-232 - Rev 04
Simvastatin
Mar 2022—
TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - JaffaIL
R1-CEP 2013-338 - Rev 01
Simvastatin, Ethanol/acetonitrile/BHA process
Dec 2021—
HETERO LABS LIMITED HyderabadIN
R1-CEP 2014-058 - Rev 00
Simvastatin
Aug 2021—
Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou CityCN
R1-CEP 2002-172 - Rev 04
Simvastatin
Mar 2021—
LUPIN LIMITED MumbaiIN
R1-CEP 2005-100 - Rev 06
Simvastatin
Aug 2020—
Artemis Biotech (A Division of Themis Medicare Limited) HyderabadIN
R1-CEP 2006-091 - Rev 03
Simvastatin, Butylated Hydroxy Anisole 50 - 150 ppm
May 2020—
ZHEJIANG JIANGBEI PHARMACEUTICAL CO., LTD. Taizhou CityCN
R1-CEP 2013-025 - Rev 03
Simvastatin, Antioxidant butylated hydroxyanisole
Jul 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (14)

Organisations whose Type II DMFs for Simvastatin are no longer active. These show a past filing, not current supply.

Show all 14 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (55 listed products contain Simvastatin). The latest listed patent expires 23 Feb 2030. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Simvastatin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1064).

Chemical identity

IUPAC name
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
Canonical SMILES
CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
InChIKey
RYMZZMVNJRMUDD-HGQWONQESA-N
Synonyms
C10AA01, Flolipid, Lacersa, MK-0733, MK-733, NSC-758706, Ranzolont, Simvador, Simvastatin, Simvastatina, Simvastatin component of juvisync, Simvastatin component of polycap

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
HMG-CoA Reductase Inhibitor
Mechanism of action
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Simvastatin?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Simvastatin: Teva Pharmaceutical Industries Ltd. (Israel), Zhejiang Jiangbei Pharmaceutical Co., Ltd. (China), Biocon Limited (India), HENAN TOPFOND SCI-TECH CO LTD (China), Hetero Labs Limited (India), Lupin Limited (India), ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTD and JUBILANT BIOSYS LTD (India), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Simvastatin Drug Master Files are active?

Teva Pharmaceutical Industries Ltd. (DMF 14599, 25024), Zhejiang Jiangbei Pharmaceutical Co., Ltd. (DMF 26971, 28583), Biocon Limited (DMF 18449, 16094), HENAN TOPFOND SCI-TECH CO LTD (DMF 34089), Hetero Labs Limited (DMF 23012, 27231), Lupin Limited (DMF 17934), ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTD (DMF 40384) and JUBILANT BIOSYS LTD (DMF 18755) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Simvastatin records mean?

14 organisations have only inactive Type II DMFs for Simvastatin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Simvastatin have a European Certificate of Suitability?

Yes. 14 organisations hold a valid CEP for Simvastatin on the EDQM register, including BIOCON LIMITED Bengaluru (IN), TAPI NL B.V. Amsterdam (NL), SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu (CN), ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai City (CN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN) and ARTEMIS BIOTECH LIMITED Hyderabad (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Simvastatin?

Yes. The latest patent listed for an approved US product containing Simvastatin expires 23 Feb 2030, across 55 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Simvastatin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Simvastatin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.